Transcriptomics

Dataset Information

0

Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand


ABSTRACT: Most studies on TCF7L2 SNP variants in the pathogenesis of type 2 diabetes (T2D) focus on a role of the encoded transcription factor TCF4 in β-cells. Here, a mouse genetics approach shows that removal of TCF4 from β-cells does not affect their function, while manipulating TCF4 levels in the liver has major effects on metabolism. In Tcf7l2-/- mice, the immediate postnatal surge in liver metabolism does not occur. Consequently, pups die due to hypoglycemia. Combining chromatin immunoprecipitation with gene expression profiling, we identify a TCF4-controlled metabolic gene program that is acutely activated in the postnatal liver. In concordance, adult liver-specific Tcf7l2 knockout mice show reduced hepatic glucose production during fasting and display improved glucose homeostasis when maintained on high-fat diet. Furthermore, liver-specific TCF4 overexpression increases hepatic glucose production. These observations imply that TCF4 directly activates metabolic genes, and that inhibition of Wnt signaling may be beneficial in metabolic disease.

ORGANISM(S): Mus musculus

PROVIDER: GSE41284 | GEO | 2012/11/01

SECONDARY ACCESSION(S): PRJNA176444

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-11-01 | E-GEOD-41284 | biostudies-arrayexpress
2021-12-11 | GSE164442 | GEO
2011-09-12 | E-GEOD-28782 | biostudies-arrayexpress
2011-09-12 | GSE28782 | GEO
| PRJNA690720 | ENA
2020-07-29 | GSE138781 | GEO
2023-01-09 | GSE162449 | GEO
| PRJNA273063 | ENA
2019-11-09 | GSE140142 | GEO
2016-02-19 | E-GEOD-65119 | biostudies-arrayexpress